Effects of Dexmedetomidine-Remifentanil on Neurodevelopment of Children after Inhalation Anesthesia: A Randomized

Sang-Hwan Ji1, Pyoyoon Kang2, Sung-Ae Cho3

  • 1Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

Anesthesiology
|September 9, 2025
PubMed

Insights

Adding dexmedetomidine and remifentanil to sevoflurane anesthesia did not impact neurodevelopmental outcomes in young children at 28-30 months. This study found no significant differences in cognitive or behavioral assessments between the groups.

Area of Science:

  • Pediatric Anesthesiology
  • Neurodevelopmental Toxicology
  • Clinical Trial Research

Background:

  • Concerns exist regarding the neurodevelopmental safety of volatile anesthetics in young children.
  • Preclinical studies suggest potential neurotoxicity associated with anesthetic agents.

Purpose of the Study:

  • To evaluate if combining dexmedetomidine and remifentanil with sevoflurane affects neurodevelopmental outcomes in young children.
  • To compare neurodevelopmental status in children receiving sevoflurane alone versus sevoflurane with dexmedetomidine and remifentanil.

Main Methods:

  • Prospective, double-blind, randomized clinical trial involving children under 2 years undergoing surgery.
  • Participants received either sevoflurane alone (control) or sevoflurane with dexmedetomidine and remifentanil (DEX-R).
  • Neurodevelopmental status assessed at 28-30 months using the Korean Leiter International Performance Scale and Child Behavior Checklist.

Main Results:

  • No significant difference in anesthesia duration between the control and DEX-R groups.
  • Mean end-tidal sevoflurane concentration was significantly lower in the DEX-R group (P < 0.001).
  • No significant difference in mean full-scale IQ scores (102.5 DEX-R vs. 103.6 control) or Child Behavior Checklist scores between groups.

Conclusions:

  • The combination of dexmedetomidine and remifentanil with sevoflurane anesthesia did not lead to significant differences in neurodevelopmental outcomes at 28-30 months.
  • Results suggest that this anesthetic combination is safe regarding neurodevelopmental outcomes in the assessed age group.
  • Further long-term follow-up is planned to report the primary endpoint of full-scale IQ at 5 years of age.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
611
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
1.5K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
687
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
776